Insights On Drug Development

  1. Budget For Drug Development Without Breaking The Bank Or Your Molecule 9/18/2025

    Early-stage biopharma teams face tough choices in injectable development. A strategic middle ground may be the smartest path to avoid the risk of under- and overspending.

  2. Mobilizing Science, Partnership, And Capability To Develop A Gene Therapy In 14 Months 9/17/2025

    Hear how one family, driven by urgency, partnered with AAV experts to develop a treatment for their daughter’s ultra-rare neurodegenerative disorder, NEDAMSS, in just 14 months.

  3. Cell-Based Screening Assay For Cholesterol Biosynthetic Pathway Inhibition 9/17/2025

    Using the RapidFire 365 HTMS platform, see how we were able to provide the sensitivity, speed, and throughput necessary to accelerate screening of large compound libraries and address challenges in oncology drug discovery.

  4. Nitrosamine Testing: How To Ensure Regulatory Compliance, Product Safety 9/16/2025

    Explore what nitrosamines are, why testing matters, and how we're able to deliver high-confidence solutions through advanced science and industry-leading expertise.

  5. Thermofluor Screening For Injectable Protein Formulations 9/15/2025

    The results herein highlight thermofluor screening as a versatile and efficient platform for rational formulation of injectable biologics through the acceleration of stable drug product development.

  6. Preclinical Technique To Assess Targeted Therapies For Primary, Metastatic NSCLC 9/13/2025

    To enable comprehensive evaluation of therapies targeting both primary and metastatic tumors, we've developed dual-disease xenograft models using bioluminescence imaging (BLI).

  7. Unlock The 3 Keys To Drug Discovery Success — Foresight, Hindsight, And Insight 9/13/2025

    If you don’t know where you are going, how will you get there? Articulating the destination of your therapeutic is essential for determining whether it is commercially viable and meets required milestones.

  8. Developing A Control Strategy And Minimizing Risk In Phase 1 Injectable Drug Development 9/11/2025

    See how investing early in the right controls not only minimizes risks but also accelerates timelines, streamlines regulatory interactions, and builds trust across the ecosystem.

  9. Early-Stage Drug Development: Navigating The Trends That Shape Tomorrow's Therapies 9/11/2025

    From AI to adaptive trial designs, the industry is undergoing a transformation that is equal parts scientific breakthrough and strategic recalibration. Learn what innovations are poised to redefine pipelines.

  10. Nanoforming Biologics, GLP-1s: From I.V. To Sub Q And Inhaled Delivery 9/9/2025

    Developing new delivery routes is essential for creating more effective treatments. Nanoforming enables new routes to simplify dosing, enhance patient comfort, and reduce healthcare costs.